Status: Not yet recruiting
Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Panzyga for Prevention of Major Infection in Patients with Hypogammaglobulinemia and Autoimmune or Rheumatic Conditions Receiving Treatment with B-cell Depletion Therapy
Participants needed: 360
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: OctapharmaUpdated: Jun 17, 2026
Eligibility criteria
Are ≥18 years of age at time of informed consent, have been diagnosed with a rhe... [+3]
Have a history of anaphylaxis or severe systemic response to immunoglobulin, blo... [+16]